BioCanRx Consortium

BioCanRx is a Canadian network of centres of excellence dedicated to accelerating the development of next-generation cancer immunotherapies. The consortium bridges the gap between early-stage academic discoveries and clinical trials by providing funding, expertise, and access to specialized manufacturing facilities. Its portfolio focuses on innovative modalities such as oncolytic viruses, adoptive cell therapies like CAR-T, and therapeutic vaccines. By fostering collaboration between academia, industry, and patients, BioCanRx aims to bring curative biotherapies to Canadian cancer patients more efficiently. The organization also supports the development of a robust biomanufacturing sector within Canada to ensure sustainable access to these advanced treatments.